Aegros welcomes the Vietnam Ministry of Health delegation to Macquarie Park – the first overseas government to visit and inspect our Haemafrac® technology, and our newly completed plant.
Aegros was honoured to welcome a high-level delegation from the Ministry of Health of the Socialist Republic of Vietnam to its newly completed Macquarie Park facility on 19 June 2026. This marked a significant moment in Aegros’ international engagement as the first visit by a foreign government to our newly completed plasma fractionation plant. Led […]
Aegros Completes Haemafrac® Plasma Fractionation Facility and Undertakes First Fractionation Runs in Macquarie Park
SYDNEY, AUSTRALIA, 3rd July 2026 – Aegros Therapeutics today announced the completion of its Haemafrac® plasma fractionation facility at Macquarie Park, Sydney. Capable of processing 125,000 litres of human plasma annually, the facility is now undertaking commissioning and engineering fractionation runs ahead of its first TGA GMP regulatory audit this year. A Reimagined Approach to […]
Aegros Strengthens Board with Appointment Of Dr Paul MacLeman as Non-Executive Director
4th May 2026 Aegros has appointed Dr Paul MacLeman BVSc MBA GAICD to its Board as a Non-Executive Director, bringing deep expertise in biopharmaceutical development, finance, ASX-listed company governance, and specialty biologics commercialisation. Dr MacLeman’s career spans executive leadership across multiple ASX, CSE and NASDAQ listed and private life sciences companies. He served as SVP […]
